Company news
Fortrea Holdings Inc. (NASDAQ:FTRE) news
Every Fortrea Holdings Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Fortrea Reports Second Quarter 2026 Results
July 29, 2026
Fortrea Announces Date for Second Quarter 2026 Financial Results and Conference Call
July 13, 2026
Fortrea Names Jason Knoblauch as Chief Financial Officer
June 26, 2026
Fortrea to Attend Jefferies Global Healthcare Conference
June 2, 2026
Fortrea Reports First Quarter 2026 Results
May 5, 2026
Fortrea Announces Date for First Quarter 2026 Financial Results and Conference Call
April 21, 2026
Fortrea Unveils Fortrea Intelligent Technology™ to Help Sponsors and Sites Run Smarter, More Integrated Trials
April 7, 2026
Fortrea Reports Fourth Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance
February 26, 2026
Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services
February 17, 2026
Fortrea Announces Date for Fourth Quarter and Full Year 2025 Financial Results and Conference Call
January 29, 2026
Fortrea Announces Updated Presentation Time at Upcoming J.P. Morgan Healthcare Conference
January 9, 2026
Fortrea to Present at Upcoming J.P. Morgan Healthcare Conference
January 6, 2026
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
December 10, 2025
SCTbio and Fortrea Forge Strategic Collaboration to Accelerate Cell and Gene Therapy Development and Delivery
December 4, 2025
Fortrea to Present at Upcoming Citi and Evercore Healthcare Conferences
November 25, 2025
Fortrea Completes $75.7 Million Senior Notes Tender Offer Utilizing Cash on Hand
November 24, 2025
Fortrea Appoints Agnieszka Gallagher as General Counsel
November 17, 2025
Velocity Clinical Research Appoints Former Fortrea Executive, Andrew Reina, as Chief Revenue Officer
November 12, 2025
Fortrea Reports Third Quarter 2025 Results
November 5, 2025
Fortrea Announces Tender Offer for up to $75,744,000 Aggregate Purchase Price of Outstanding Debt
October 20, 2025
Fortrea Announces Date for Third Quarter 2025 Financial Results and Conference Call
October 15, 2025
Fortrea Appoints William Sharbaugh to Board of Directors
September 22, 2025
Fortrea Reports Second Quarter 2025 Results
August 6, 2025
Fortrea Appoints Tracy Krumme as Senior Vice President, Investor Relations
August 5, 2025
Fortrea Announces Date for Second Quarter 2025 Financial Results and Conference Call
July 16, 2025
Avant Technologies and JV Partner, Ainnova, Complete Pivotal Meeting with U.S. FDA
July 15, 2025
Avant Technologies and JV Partner, Ainnova, Prepare for Key FDA Milestone with Next Week's Pre-Submission Meeting
June 30, 2025
Fortrea & Emery Pharma Announce Strategic Collaboration to Deliver FDA Compliant Drug-Drug-Interaction Studies Using Rifampin
June 24, 2025
Fortrea Adopts Limited-Duration Stockholder Rights Plan
June 12, 2025
Fortrea Names Anshul Thakral Chief Executive Officer
June 11, 2025
Fortrea to Present at the Jefferies Global Healthcare Conference
June 3, 2025
Fortrea Announces CEO Stepping Down
May 12, 2025
Fortrea Reports First Quarter 2025 Results
May 12, 2025
Fortrea Named a Leader in Everest Group’s Pharmacovigilance Operations PEAK Matrix® Assessment 2025
May 1, 2025
Fortrea Announces Date for First Quarter 2025 Financial Results and Conference Call
April 15, 2025
Fortrea Reports Fourth Quarter and Full-Year 2024 Results; Issues Full-Year 2025 Guidance
March 3, 2025
Fortrea to Add Erin L. Russell to Board of Directors
February 21, 2025
Fortrea Announces Date for Fourth Quarter and Full Year 2024 Financial Results and Conference Call
January 30, 2025
Fortrea to Present at the Evercore HealthCONx Conference
November 26, 2024
Fortrea to Present at the Citi Global Healthcare Conference
November 26, 2024
Fortrea Reports Third Quarter 2024 Results
November 8, 2024
Fortrea Releases Inaugural Corporate Social Responsibility Report
October 17, 2024
Fortrea Announces Date for Third Quarter 2024 Financial Results and Conference Call
October 14, 2024
Fortrea Reports Second Quarter 2024 Results
August 12, 2024
Fortrea Announces Date for Second Quarter 2024 Financial Results and Conference Call
July 17, 2024
Fortrea Appoints Robert Parks as Chief Accounting Officer
July 11, 2024
Fortrea Launches AI Innovation Studio to Galvanize Technology and Human Solutions to Improve Clinical Trial Delivery
June 27, 2024
Fortrea to Participate in Virtual Fireside Chat with Evercore ISI
June 19, 2024
Fortrea Completes Divestiture of Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners
June 4, 2024
Fortrea Introduces Comprehensive Solution to Improve Diversity and Inclusion in Clinical Research
May 30, 2024